Home > Healthcare > Biotechnology > Biotechnology R&D > Non-animal Alternative Testing Market

Non-animal Alternative Testing Market Share

Report ID: GMI5704
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Non-animal Alternative Testing Market Share

The competition in the industry is marked by intense rivalry, driven by the increasing demand for these test methods. In addition to global leaders, advanced formulations tailored to specific advantages or accurate results are emerging, particularly in regions like North America, where technological advancements are highly emphasised. New innovations in the non-animal alternative testing is key competitive factor, with companies partnering with other manufacturers or research organizations to create high quality non-animal alternative testing methods that provides efficient results.

Non-animal Alternative Testing Market Companies

Prominent players operating in the non-animal alternative testing industry include:

AlveoliX
BICO GROUP
CN Bio Innovations
Emulate
Hesperos
InSphero
Lonza Group
Merck
MIMETAS
Thermo Fisher Scientific
TissUse
VITROCELL Systems

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global non-animal alternative testing industry was valued at approximately USD 1.8 billion in 2023 and is estimated to grow at an 11.9% CAGR from 2024 to 2032, driven by increasing investments and research grants for alternative technologies.

The cell lines segment dominated the market in 2023, accounting for USD 1.2 billion, due to their extensive use in drug development, toxicity testing, and biological research.

The U.S. non-animal alternative testing industry is forecasted to reach USD 1.9 million by 2032, having dominated the North American market with a revenue of USD 656.6 million in 2023.

Increasing public awareness and ethical concerns about animal testing are driving pharmaceutical companies to adopt non-animal testing methods, influenced by consumer demand for more humane research practices.

Key players in the industry include AlveoliX, BICO GROUP, CN Bio Innovations, Emulate, Hesperos, InSphero, Lonza Group, Merck, MIMETAS, Thermo Fisher Scientific, TissUse, and VITROCELL Systems.